FUNDING INFORMATION
The study was funded by Novartis Pharma AG, Basel, Switzerland. The TANDEM study was funded by Novartis Pharma AG. Quentin M. Anstee is an NIHR senior investigator supported by the Newcastle NIHR Biomedical Research Center.